Analysing the Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 and Coronavirus Anxiety Scales

January 30, 2021 updated by: Esra Oz, Suleyman Demirel University

Suleyman Demirel University Faculty of Dentistry Pediatric Dentistry Department

The aims of this study were to (i) assess fear and anxiety of COVID-19 in a Turkish sample dental professionals using the Turkish FCV-19S and CAS; (ii) explore factors associated with FCV-19S and CAS; and (iii) examine the psychometric properties of the Turkish FCV-19S and CAS.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

This cross-sectional study was conducted between October, 16 to 23, 2020 by sending an online survey questionnaire working in public and university hospitals, including general dentists or specialists. The tool utilized for data collection was a designed online Google Forms questionnaire.

This survey was implemented by using a questionnaire that included socio-demographic data (age range, gender, marital status, systemic disease, professional area, years of clinical experience, number of patients treated daily, smoking status, alcohol consumption, vs), epidemic-related questions and scales measuring the fear and anxiety levels of the participants.

Fear of COVID-19 Scale is an unidimensional scale seven-item scale assessing anxiety regarding COVID-19 developed by Ahorsu et al. Items are rated on a 5-item Likert scale from 1 (Strongly disagree) to 5 (Strongly agree) with scores ranging from 7 to 35. A higher score of the FCV-19S represents a greater level of fear. In the study, the bi-factor model and two-factor model consisting of the "emotional response" factor (items 1, 2, 4, and 5) and "physiological response" factor (items 3, 6, and 7) were used.

Coronavirus Anxiety Scale is an unidimensional tool that assesses the physiological reactions anxiety related to the COVID-19 pandemic. Participants were asked to rate 5 items on a 5-point Likert-type scale, from 0 (not at all) to 4 (nearly every day over the last 2 weeks).

Study Type

Interventional

Enrollment (Actual)

850

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
      • Isparta, Turkey, 32260
        • Suleyman Demirel University Faculty of Dentistry Pediatric Dentistry Department

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

23 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Dental professionals working in public hospitals
  • Dental professionals working in university hospitals

Exclusion Criteria:

  • Dental professionals working in private clinics

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: NA
  • Interventional Model: SINGLE_GROUP
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
OTHER: Analysing the psychosocial effects of COVID-19 pandemic on dental professionals
Dental professionals
Behavioral: The psychosocial effects of COVID-19 pandemic on dental professionals
Analysing the psychosocial effects of COVID-19 pandemic on dental professionals using the Turkish version of the Fear of COVID-19 and Coronavirus Anxiety Scales

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Psychosocial Effects of COVID-19 Pandemic on Dental Professionals Using the Turkish Version of the Fear of COVID-19 Scale
Time Frame: during the survey administration
Fear of COVID-19 Scale is an unidimensional scale seven-item scale assessing anxiety regarding COVID-19 . Items are rated on a 5-item Likert scale from 1 (Strongly disagree) to 5 (Strongly agree) with scores ranging from 7 to 35. Scores are added up. A higher score of the FCV-19S represents a greater level of fear and a worse outcome.
during the survey administration

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
The Psychosocial Effects of COVID-19 Pandemic Using the Turkish Version of the Coronavirus Anxiety Scale
Time Frame: during the survey administration
Coronavirus Anxiety Scale is an unidimensional tool that assesses the physiological anxiety related to the COVID-19. Participants rated 5 items on a 5-point Likert-type scale, from 0 (not at all) to 4 (nearly every day over the last 2 weeks). Scores are added up for a total score of 0 - 20, with higher scores indicating worse outcomes.
during the survey administration

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Suleyman Demirel University

Investigators

  • Principal Investigator: esra Oz, Assist Prof, Suleyman Demirel University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

October 16, 2020

Primary Completion (ACTUAL)

October 23, 2020

Study Completion (ACTUAL)

October 23, 2020

Study Registration Dates

First Submitted

December 16, 2020

First Submitted That Met QC Criteria

December 17, 2020

First Posted (ACTUAL)

December 19, 2020

Study Record Updates

Last Update Posted (ACTUAL)

February 2, 2021

Last Update Submitted That Met QC Criteria

January 30, 2021

Last Verified

January 1, 2021

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 355

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on COVID-19 Pandemic

Clinical Trials on The psychosocial effects of COVID-19 pandemic on dental professionals

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belarus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe